SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,354,056 | -12.0% | 534,345 | -0.2% | 0.16% | -9.0% |
Q2 2023 | $14,033,835 | -2.4% | 535,234 | -4.2% | 0.18% | -12.4% |
Q1 2023 | $14,377,566 | +103.6% | 558,569 | +105.7% | 0.20% | +92.4% |
Q4 2022 | $7,061,793 | -9.7% | 271,503 | -1.0% | 0.10% | -11.0% |
Q3 2022 | $7,820,000 | -72.8% | 274,111 | -76.5% | 0.12% | -74.6% |
Q2 2022 | $28,703,000 | -72.4% | 1,165,824 | -36.7% | 0.46% | -63.6% |
Q1 2022 | $103,951,000 | -6.2% | 1,841,799 | +3.0% | 1.28% | +12.8% |
Q4 2021 | $110,814,000 | +6.8% | 1,787,902 | +9.3% | 1.13% | -8.0% |
Q3 2021 | $103,734,000 | -8.5% | 1,635,147 | +18.9% | 1.23% | -18.1% |
Q2 2021 | $113,378,000 | +22.1% | 1,375,775 | +9.0% | 1.50% | +9.6% |
Q1 2021 | $92,851,000 | +10.8% | 1,262,075 | +9.2% | 1.37% | +1.2% |
Q4 2020 | $83,783,000 | +80.3% | 1,155,309 | +18.5% | 1.35% | +41.9% |
Q3 2020 | $46,474,000 | +9.9% | 974,915 | -3.1% | 0.95% | -7.2% |
Q2 2020 | $42,277,000 | +108.7% | 1,006,602 | +34.2% | 1.03% | +51.8% |
Q1 2020 | $20,259,000 | -10.7% | 750,341 | +27.3% | 0.68% | +12.3% |
Q4 2019 | $22,689,000 | +188.1% | 589,482 | +62.3% | 0.60% | +135.5% |
Q3 2019 | $7,875,000 | – | 363,260 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |